TOFACITINIB OR USTEKINUMAB FOR THIRD-LINE TREATMENT OF REFRACTORY ULCERATIVE COLITIS: A MULTICENTER RETROSPECTIVE PROPENSITY SCORE-MATCHED ANALYSIS

Camille Meunier  1     Anne-Laure Charlois  1     Anthony Buisson  2     Xavier Roblin  3     Nicolas Mathieu  4     Pauline Danion  4     Claire Gay  4     Stephane NANCEY  4     Gilles Boschetti  4    
1 Lyon-Sud Hospital, Pierre-Benite, France
2 CHU Estaing Clermont-Ferrand, Clermont-ferrand, France
3 University of St. Etienne Dept. de Gastroenterologie, Saint Etienne, France
4 Hôpital Albert Michallon, La Tronche, France

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing